InvestSMART

Firebrick Pharma Limited (ASX: FRE) - Announcements

- Current share price for FRE : $0.028

ASX company news and announcements for Firebrick Pharma Limited (FRE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Firebrick Pharma Limited (FRE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Firebrick Pharma Limited (FRE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Firebrick Pharma Limited (FRE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$9 Nasodine Phase 3 Common Cold Trial Published 10 Jun 2025 8:38AM $0.067 $0.028 fallen by 58.21%
$9 Withdrawal of Share Placement 6 Jun 2025 4:58PM $0.067 $0.028 fallen by 58.21%
$9 Trading Halt 5 Jun 2025 9:09AM $0.067 $0.028 fallen by 58.21%
$9 March 2025 Quarterly Activity Report & Appendix 4C 16 Apr 2025 10:56AM $0.080 $0.028 fallen by 65%
$9 Cleansing Notice 28 Mar 2025 2:58PM $0.091 $0.028 fallen by 69.23%
$9 Application for quotation of securities - FRE 28 Mar 2025 2:56PM $0.091 $0.028 fallen by 69.23%
$9 Cleansing Notice 21 Mar 2025 3:33PM $0.093 $0.028 fallen by 69.89%
$9 Application for quotation of securities - FRE 21 Mar 2025 3:32PM $0.093 $0.028 fallen by 69.89%
$9 Becoming a substantial holder - Pharma Nutria NA Inc 6 Mar 2025 12:02PM $0.094 $0.028 fallen by 70.21%
$9 Becoming a substantial holder - Firebrick Pharma 6 Mar 2025 10:08AM $0.092 $0.028 fallen by 69.57%
$9 Change in substantial holding - Stephen Goodall 6 Mar 2025 10:07AM $0.092 $0.028 fallen by 69.57%
$9 Change in substantial holding - Peter Molloy 6 Mar 2025 10:06AM $0.092 $0.028 fallen by 69.57%
$9 Cleansing Notice 5 Mar 2025 11:06AM $0.092 $0.028 fallen by 69.57%
$9 Application for quotation of securities - FRE 5 Mar 2025 11:04AM $0.092 $0.028 fallen by 69.57%
$9 Proposed issue of securities - FRE 4 Mar 2025 9:12AM $0.090 $0.028 fallen by 68.89%
$9 FRE secures Strategic Investment from Philippines Partner 4 Mar 2025 9:11AM $0.090 $0.028 fallen by 68.89%
$9 Trading Halt 28 Feb 2025 9:23AM $0.090 $0.028 fallen by 68.89%
$9 Webinar on Firebrick Half-Year Results and 2025 Plans 20 Feb 2025 3:40PM $0.084 $0.028 fallen by 66.67%
$9 Appendix 4D & Half-Year Financial Report to 31 December 2024 20 Feb 2025 3:20PM $0.083 $0.028 fallen by 66.27%
$9 Nasodine to be Launched in Fiji and South Pacific 12 Feb 2025 8:52AM $0.083 $0.028 fallen by 66.27%
$9 December 2024 Quarterly Activity Report & Appendix 4C 23 Jan 2025 8:36AM $0.063 $0.028 fallen by 55.56%
$9 Successful Nasodine Patent Defense in Singapore 13 Jan 2025 5:29PM $0.061 $0.028 fallen by 54.10%
$9 Notification regarding unquoted securities - FRE 20 Dec 2024 9:24AM $0.054 $0.028 fallen by 48.15%
$9 Proposed issue of securities - FRE 19 Dec 2024 9:22AM $0.053 $0.028 fallen by 47.17%
$9 Consulting Agreement Extended to Grow Asia Sales 19 Dec 2024 8:29AM $0.053 $0.028 fallen by 47.17%

126 - 150 of 523 results

Page 6 of 21

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.